WALTHAM, MA — Designed for representatives of life science companies about to begin clinical trials of a product, or those looking to learn more about the process, Life Sciences Products: Navigating the Paths to Market, a program of law firm Morse, Barnes-Brown & Pendleton, features a panel of life science business executives and attorneys.
Panelist include: Dick Meijer, vice president – general manager of Canada, Australasia, Sub-Saharan Africa and the Indian Subcontinent, Genzyme Corporation; and Daniel J. Moore,
president of international distributor management,
Boston Scientific Corporation. Moderators for the event are MBBP attorneys, Jeffrey Somers and Shannon Zollo.
Panelists will discuss the options — go it alone, partner, license it out, and others — and the benefits and pitfalls of each. The program will also include a question and answer session and networking reception.
The event takes place Tuesday, March 6, 2007 from 6:00 p.m. to 9:00 p.m. at the Royal Sonesta Hotel Boston, 5 Cambridge Parkway, Cambridge, MA. To register online, click here. Or, contact Judy Truglia by email: or by phone at: 781-622-5930. Please register by February 27. There is no cost to register. Space is limited and may be filled quickly.
Morse, Barnes-Brown Pendleton, PC, focuses exclusively on the core legal services that businesses need to succeed. The law firm assists businesses of all sizes — from start-ups to Fortune 1000 companies — in the areas of business law, technology and intellectual property, employment and immigration and taxation.
Morse, Barnes-Brown Pendleton, PC
Reservoir Place
1601 Trapelo Road, Suite 205
Waltham, MA 02451
781-622-5930
mbbp.com
FOR IMMEDIATE RELEASE
February 16, 2007
For more information,
please
contact
Judy Truglia
781-622-5930